US Food and Drug Administration (USFDA) has completed audit of Dr. Reddy’s Laboratories’ Formulations Srikakulum Plant (SEZ) Unit II, Andhra Pradesh on May 25, 2017 with zero observations.
Recently, USFDA had completed audit of the company’s Formulations Manufacturing Plant – 3 at Bachupally, Hyderabad on April 28, 2017. The company had been issued a Form 483 with 11 observations.
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.